Scientists Come Together to Discover Possible Cures for Neurodegenerative Diseases

Released on = August 30, 2005, 3:35 pm

Press Release Author = GTCbio

Industry = Biotech

Press Release Summary = GTCbio's conference on Therapeutic Strategies against Neurodegenerative Conditions will be held October 10-11, 2005 at the Boston Marriott Burlington. Over 30 speakers from academia, industry and government organizations will present during this event.

Press Release Body = MONROVIA - More than one million people suffer from neurodegenerative conditions of the central nervous system in the United States alone. Yet there are currently no cures and very few treatments for diseases such as Parkinson's and Alzheimer's. On October 10 & 11, 2005, over 30 speakers from
academia, industry and government organizations will come together at GTCbio’s conference on Therapeutic Strategies against Neurodegenerative Conditions with the common goal of discovering potential therapies for such conditions.
<P>
Steven M. Paul, President of Lilly Research Laboratories and Vice President of Eli Lilly & Company, will deliver one of two keynote addresses. Paul has authored or co-authored more than 450 papers and invited book chapters and serves on the editorial boards of numerous scientific journals. He has been listed as one of the
most highly cited neuroscientists in the world (1980-2000) by the I.S.I., Philadelphia, PA.
<P>
Delivering a keynote address on Day 2 entitled “Apoptosis and Neurodegeneration: Death is in the Details” will be Dr. Kevin A. Roth the Director of Neuropathology at the University of Alabama at Birmingham. In addition to his research, clinical and teaching responsibilities, Dr. Roth is an Associate Editor for the American Journal of Pathology and the Journal of Histochemistry and Cytochemistry. <P>
The conference will also feature presentations from Amgen, Bucks Institute for Age Research, The Biologics Consulting Group, The Burnham Institute, Columbia University, Curis Inc., Elan Pharmaceuticals, Eli Lilly & Company, En Vivo Pharmaceuticals, GlaxoSmithKline, Guilford Pharmaceuticals, Harvard Medical School,
Lundbeck, Memory Pharmaceuticals, Merck Research Laboratories, Neuroventures, NIHM-NIH, NINDS-NIH, Oxford Bioscience Partners, Palmer & Dodge, Pfizer Global Research, Recombinant Capital Inc., Rinat Neuroscience, PsychoGenics Inc., Satori Pharmaceuticals Inc., University of North Texas, University of Texas at Dallas,
University of Ottawa and Wyeth Research.
<P>
The event is presented by GTCbio and will take place at the Boston Marriott Burlington in Burlington, Massachusetts. More information including a detailed agenda, exhibitor opportunities and registration information can be found at http://www.gtcbio.com/confpage.asp?cid

Web Site = http://www.gtcbio.com

Contact Details = 434 W. Foothill Blvd.
Monrovia, CA 91016
626-256-6405
christy.bowman@gtcbio.com